What eye care companies will be hiring in the future?

Quote






Novartis, eye point, eyevance, BL, Sun, maybe Kala and Dompé if they expand.

The goals here are ridiculous and not attainable. No change in managed care...this place is a joke.
 






Ocular Therapeutics has been calling but hear they are having manufacturing issues and may not even get approved. Novartis retina or EyePoint seem to be the best potential options. Those would both get me away from selling “drops” and dealing with retail pharmacy issues!
 






anonymous said:
Ocular Therapeutics has been calling but hear they are having manufacturing issues and may not even get approved. Novartis retina or EyePoint seem to be the best potential options. Those would both get me away from selling “drops” and dealing with retail pharmacy issues!
Click to expand...

EyePoint, so confident in their product that they went contract. Ask yourself that question. At least Kala hired a sales force. Eyevance is a sketchy outfit, think Sun on steroids, selling Alcon throwaways.
 






anonymous said:
Novartis, eye point, eyevance, BL, Sun, maybe Kala and Dompé if they expand.

The goals here are ridiculous and not attainable. No change in managed care...this place is a joke.
Click to expand...

Kala is a big risk, if they don’t get their DED indication, they’ll layoff the entire sales force. Plus B&L has a submicron lotemax coming next year. Enjoy the no acess discussions w Docs. Makes Xiidra look like a piece of cake.

Eyepoint has a contract salesforce, ask them why? Zero risk when laying off, speaks to the confidence of their “cutting edge drugs”, not. Buy and build experience is the pitch. That “skill is an easy learn”.

Sun, enough said. Eyevance, see Sun. Dompe is the only company that has an innovative product that will have long term impact if they have a strong business approach. The rest are rehashed commodity drugs w zero innovation and minimal long term success.
 












I’m not saying the EyePoint opportunity is perfect but the contract piece is not a concern. We are all contract; just ask Takeda on 1/8 or simply look at your current pay stub that says “Sarcode”. If they’ll pay me enough and I can get into injectible surgery or injectible retina; I’ll jump. I asked around and at least docs are interested in their products. I’d be selling a product not a mail order service! Dompe seems unique as well; but hear their infrastructure is a mess. The Novartis retina may be a good gig too. No thanks to Sun, Eyevance, or Kala.
 






anonymous said:
Kala is a big risk, if they don’t get their DED indication, they’ll layoff the entire sales force. Plus B&L has a submicron lotemax coming next year. Enjoy the no acess discussions w Docs. Makes Xiidra look like a piece of cake.

Eyepoint has a contract salesforce, ask them why? Zero risk when laying off, speaks to the confidence of their “cutting edge drugs”, not. Buy and build experience is the pitch. That “skill is an easy learn”.

Sun, enough said. Eyevance, see Sun. Dompe is the only company that has an innovative product that will have long term impact if they have a strong business approach. The rest are rehashed commodity drugs w zero innovation and minimal long term success.
Click to expand...
So on point! Thanks but I still see Dompe as a very high risk.
 






anonymous said:
I’m not saying the EyePoint opportunity is perfect but the contract piece is not a concern. We are all contract; just ask Takeda on 1/8 or simply look at your current pay stub that says “Sarcode”. If they’ll pay me enough and I can get into injectible surgery or injectible retina; I’ll jump. I asked around and at least docs are interested in their products. I’d be selling a product not a mail order service! Dompe seems unique as well; but hear their infrastructure is a mess. The Novartis retina may be a good gig too. No thanks to Sun, Eyevance, or Kala.
Click to expand...
 






anonymous said:
I’m not saying the EyePoint opportunity is perfect but the contract piece is not a concern. We are all contract; just ask Takeda on 1/8 or simply look at your current pay stub that says “Sarcode”. If they’ll pay me enough and I can get into injectible surgery or injectible retina; I’ll jump. I asked around and at least docs are interested in their products. I’d be selling a product not a mail order service! Dompe seems unique as well; but hear their infrastructure is a mess. The Novartis retina may be a good gig too. No thanks to Sun, Eyevance, or Kala.
Click to expand...
“Contract piece is not a concern”? This person must either be a mgt at Eyepoint or waiting to go there. I say waiting Because they keep moving their start date back because they dont have enough money or they don’t have their shit together. Dexycu is a shit product too. I have asked many docs about this product and it doesn’t Benefit them nor the patient. But messaging will be around patient compliance? I’d rather stay at Shire. OcularTherapeutics is the safer route.
 






I posted about not being concerned about the contract. No, I’m not headed to EyePoint. I’m hoping for Novartis retina in 6-8 weeks. In this environment, I wouldn’t be that concerned with the contract component. I simply wouldn’t go to one of these other companies and sell the same drops and deal with the same MC issues. I respect your thoughts and opinions; to each their own. Good luck!
 






“OcularTherapeutics is the safer route”. One of my docs is an advisor for them. He told me they just got cited by FDA with more manufacturing issues and said they may never get approved as they’ve had the same issues for 3 years. I have no idea but just do your research before jumping over there.
 












I’ve been talking to several of these companies and they all know we are “big pharma”. I spend most of my time trying to overcome that perception. I stayed here too long.
 






NovaBay is hiring in select markets. They will pay for experience. Currently rebuilding the sales force under a new CEO. They have little to no managed care and no expectations or goals that refelect them having coverage. Kind of the opposite of Shire OBU.
 












Why would I want to leave? I’m making awesome bonus while selling a product with great managed care coverage while working for leadership that provides open and honest communication.
 






anonymous said:
NovaBay is hiring in select markets. They will pay for experience. Currently rebuilding the sales force under a new CEO. They have little to no managed care and no expectations or goals that refelect them having coverage. Kind of the opposite of Shire OBU.
Click to expand...
No way NovaBay is going to survive without MC coverage.
 






Novartis will not be hiring many "exteernal" eye reps. Internal transfer is the vast majority of job openings. In addition, I heard that several companies' reps, including Shire, will not be given an opportunity due to their launch performance. Sorry for the update.
 












Top Bottom
Back
Quote